Late toxicity after postprostatectomy salvage radiation therapy

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 203-206

  Peterson, Jennifer L ^a   Buskirk, Steven J ^a   Heckman, Michael G ^b   Crook, Julia E ^b   Ko, Stephen J ^a   Wehle, Michael J ^a   Igel, Todd C ^a   Prussak, Karin A ^a   Pisansky, Thomas M ^a  

^a Department of Radiation Oncology ^*  (United States)

^b Biostatistics Unit   (United States)

Author keywords

Adjuvant therapy; Prostate specific antigen; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CYSTITIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PHOTON; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM DISEASE; RETROSPECTIVE STUDY; SALVAGE THERAPY; URETHRA STRICTURE;

ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 70350515449     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.035     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 59 (2009) 225-249
2. Stephenson R.A. Prostate cancer trends in the era of prostate-specific antigen: an update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am 29 (2002) 173-181
3. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. CaPSURE Investigators. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol 2004;171:1393-401.
4. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
5. Pisansky T.M., Kozelsky T.F., Myers R.P., Hillman D.W., Blute M.L., Buskirk S.J., et al. Radiotherapy for isolated serum prostate-specific antigen elevation after prostatectomy for prostate cancer. J Urol 163 (2000) 845-850
6. Stephenson A.J., Scardino P.T., Kattan M.W., Pisansky T.M., Slawin K.M., Klein E.A., et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25 (2007) 2035-2041 Erratum in: J Clin Oncol 2007;25:4153
7. Buskirk S.J., Pisansky T.M., Schild S.E., Macdonald O.K., Wehle M.J., Kozelsky T.F., et al. Salvage radiotherapy for isolated prostate-specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 176 (2006) 985-990
8. O'Leary MP, Baum NH, Blizzard R, Blute ML, Cooper TP, Dineen MK, et al. The Health Policy Survey and Research Committee. 2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. J Urol 2002;168:649-52.
9. Taylor N., Kelly J.F., Kuban D.A., Babaian R.J., Pisters L.L., and Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 56 (2003) 755-763
10. Zelefsky M.J., Aschkenasy E., Kelsen S., and Leibel S.A. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 39 (1997) 327-333
11. Bolla M, van Poppel H, Collette L, Van Cangh P, Vekemans K, Da Pozzo L, et al. European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572-8.
12. Formenti S.C., Lieskovsky G., Simoneau A.R., Skinner D., Groshen S., Chen S.C., et al. Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J Urol 155 (1996) 616-619
13. Jacobson G.M., Smith Jr. J.A., and Stewart J.R. Postoperative radiation therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 13 (1987) 1021-1024
14. Macdonald O.K., Schild S.E., Vora S.A., Andrews P.E., Ferrigni R.G., Novicki D.E., et al. Radiotherapy for men with isolated increase in serum prostate-specific antigen after radical prostatectomy. J Urol 170 (2003) 1833-1837
15. Pilepich M.V., Walz B.J., and Baglan R.J. Postoperative irradiation in carcinoma of the prostate. Int J Radiat Oncol Biol Phys 10 (1984) 1869-1873
16. Choo R., Hruby G., Hong J., Bahk E., Hong E., Danjoux C., et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 53 (2002) 269-276
17. Forman J.D., Duclos M., Shamsa F., and Pontes E.J. Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. Urology 47 (1996) 382-386
18. Wu J.J., King S.C., Montana G.S., McKinstry C.A., and Anscher M.S. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 32 (1995) 317-323
19. Morris M.M., Dallow K.C., Zietman A.L., Park J., Althausen A., Heney N.M., et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 38 (1997) 731-736
20. Van Cangh P.J., Richard F., Lorge F., Castille Y., Moxhon A., Opsomer R., et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 159 (1998) 164-166
21. Lennernas B., Edgren M., Haggman M., Norlen B.J., and Nilsson S. Postoperative radiotherapy after prostatectomy: a review. Scand J Urol Nephrol 37 (2003) 10-15
22. Bolla M., van Poppel H., Van Cangh P.J., Scalliet P., van den Bogaert W., Vekemans K., et al. Acute and late toxicity of post-operative external irradiation in pT3N0 prostate cancer patients treated within EORTC trial 22911 [abstract]. Int J Radiat Oncol Biol Phys 54 (2002) 62-63
23. Thompson Jr. I.M., Tangen C.M., Paradelo J., Lucia M.S., Miller G., Troyer D., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296 (2006) 2329-2335
24. Feng M., Hanlon A.L., Pisansky T.M., Kuban D., Catton C.N., Michalski J.M., et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1417-1423
25. Lerner S.E., Blute M.L., Lieber M.M., and Zincke H. Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. Oncology (Williston Park) 9 (1995) 379-382
26. Geary E.S., Dendinger T.E., Freiha F.S., and Stamey T.A. Incontinence and vesical neck strictures following radical retropubic prostatectomy. Urology 45 (1995) 1000-1006
27. Kao T.C., Cruess D.F., Garner D., Foley J., Seay T., Friedrichs P., et al. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. J Urol 163 (2000) 858-864
28. Diokno A.C., Brock B.M., Brown M.B., and Herzog A.R. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136 (1986) 1022-1025
29. Cozzarini C., Bolognesi A., Ceresoli G.L., Fiorino C., Rossa A., Bertini R., et al. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 59 (2004) 674-683
30. Poortmans P, Bossi A, Vandeputte K, Bosset M, Miralbell R, Maingon P, et al. EORTC Radiation Oncology Group. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 2007;84:121-7.